Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NKX2-2 antisense RNA 1 (NKX2-2-AS1)
- Target
- NKX2-2-AS1
- Molecular classification
- Long non-coding RNA, Antisense RNA
01
Overview
NKX2-2 antisense RNA 1 is a long non-coding RNA transcribed antisense to the NKX2-2 gene. It resides in the cytoplasm and can regulate the transcription level of NKX2-2. Overexpression of NKX2-2-AS1 in neural stem cells promotes differentiation into oligodendrocytes, a process accompanied by a modest increase in NKX2-2 mRNA levels. This suggests NKX2-2-AS1 may have biological functions not limited to the cis-regulation of NKX2-2, possibly affecting differentiation through other mechanisms as well. Current research positions NKX2-2-AS1 as a regulatory RNA important for neural development and differentiation, but its role in disease states or as a therapeutic target remains undefined[2].
- Other names
- NKX2-2ASNKX2-2 antisense RNA
02
Mechanism of action
N/A
03
Biological functions
Regulation of NKX2-2 gene transcriptionNeural stem cell differentiationOligodendrocyte differentiation
04
Disease associations
Implicated in neural development (no strong evidence yet for direct roles in cancer, inflammation, or other major disease classes)
Beyond the preview
Go deeper on NKX2-2 antisense RNA 1 (NKX2-2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NKX2-2 antisense RNA 1 (NKX2-2-AS1).